<iframe style="width:100%!important;height:75vh!important;" class="gdriveviewer-iframe" src="https://docs.google.com/gview?embedded=true&url=https://www.sochob.cl/web1/wp-content/uploads/2023/05/Perspectives-in-weight-control-in-diabetes-–-SGLT2-inhibitors-and-GLP-1–glucagon-dual-agonism.pdf"></iframe><a target="_blank" style="margin-top:2rem;display:block"  href="https://www.sochob.cl/web1/wp-content/uploads/2023/05/Perspectives-in-weight-control-in-diabetes-–-SGLT2-inhibitors-and-GLP-1–glucagon-dual-agonism.pdf">Descargar Publicación</a>{"id":18444,"date":"2023-05-08T07:55:05","date_gmt":"2023-05-08T11:55:05","guid":{"rendered":"https:\/\/www.sochob.cl\/web1\/?p=18444"},"modified":"2023-05-08T07:55:05","modified_gmt":"2023-05-08T11:55:05","slug":"perspectives-in-weight-control-in-diabetes-sglt2-inhibitors-and-glp-1-glucagon-dual-agonism","status":"publish","type":"post","link":"https:\/\/www.sochob.cl\/web1\/perspectives-in-weight-control-in-diabetes-sglt2-inhibitors-and-glp-1-glucagon-dual-agonism\/","title":{"rendered":"Perspectives in weight control in diabetes \u2013 SGLT2 inhibitors and GLP-1\u2013glucagon dual agonism"},"content":{"rendered":"\n","protected":false},"excerpt":{"rendered":"<p><img decoding=\"async\" width=\"20px;\" style=\"box-shadow:none!important;margin:0 0.5rem;\" src=\"https:\/\/www.sochob.cl\/web1\/wp-content\/plugins\/gdrive-viewer\/includes\/..\/assets\/images\/document.png\">Para ver el documento haz click <a style=\"color:#00A1E7\" data-url=\"https:\/\/www.sochob.cl\/web1\/wp-content\/uploads\/2023\/05\/Perspectives-in-weight-control-in-diabetes-\u2013-SGLT2-inhibitors-and-GLP-1\u2013glucagon-dual-agonism.pdf\" id=\"gdriver_show_document\" href=\"#\">aqu\u00ed<\/a><\/p>\n<p><p><i style=\"color: #00A1E7;\n    font-size: 20px;\n    margin: 0 0.6rem;\" class=\"fas fa-file-download\"><\/i>Para descargar el documento haz click <a style=\"color:#00A1E7\" href=\"https:\/\/www.sochob.cl\/web1\/wp-content\/uploads\/2023\/05\/Perspectives-in-weight-control-in-diabetes-\u2013-SGLT2-inhibitors-and-GLP-1\u2013glucagon-dual-agonism.pdf\">aqu\u00ed<\/a><\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[16],"tags":[],"class_list":["post-18444","post","type-post","status-publish","format-standard","hentry","category-tratamiento-de-la-obesidad"],"acf":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.sochob.cl\/web1\/wp-json\/wp\/v2\/posts\/18444","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sochob.cl\/web1\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sochob.cl\/web1\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sochob.cl\/web1\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sochob.cl\/web1\/wp-json\/wp\/v2\/comments?post=18444"}],"version-history":[{"count":1,"href":"https:\/\/www.sochob.cl\/web1\/wp-json\/wp\/v2\/posts\/18444\/revisions"}],"predecessor-version":[{"id":18446,"href":"https:\/\/www.sochob.cl\/web1\/wp-json\/wp\/v2\/posts\/18444\/revisions\/18446"}],"wp:attachment":[{"href":"https:\/\/www.sochob.cl\/web1\/wp-json\/wp\/v2\/media?parent=18444"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sochob.cl\/web1\/wp-json\/wp\/v2\/categories?post=18444"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sochob.cl\/web1\/wp-json\/wp\/v2\/tags?post=18444"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}